What clinical considerations and management steps should be considered for a 34-year-old woman with hypertension and an estimated glomerular filtration rate of 8 mL/min/1.73 m² (end-stage renal disease)?

Critical Management of End-Stage Renal Disease in a Young Hypertensive Woman

This 34-year-old woman with an eGFR of 8 mL/min/1.73 m² has Stage 5 CKD (end-stage renal disease) and requires immediate nephrology referral for renal replacement therapy planning, along with comprehensive management of ESRD complications and careful medication adjustments.

Immediate Priorities

1. Urgent Nephrology Referral

Refer immediately to nephrology 1, 2. With eGFR <15 mL/min/1.73 m², she needs discussion of renal replacement therapy options (hemodialysis, peritoneal dialysis, or kidney transplantation) 1. Consultation at this stage has been shown to reduce costs, improve quality of care, and allow for proper dialysis access planning 1.

2. Blood Pressure Management Considerations

Continue ACE inhibitors or ARBs if she's already on them, even at this low eGFR 2. The 2024 KDIGO guidelines explicitly state to continue RAS inhibitors even when eGFR falls below 30 mL/min/1.73 m² 2. However, consider reducing dose or discontinuing only if she develops:

• Symptomatic hypotension
• Uncontrolled hyperkalemia despite medical treatment
• Uremic symptoms that might improve with dose reduction 2

Target BP <130/80 mmHg using standardized office measurement 3. In ESRD patients, BP control becomes complex due to volume status and dialysis-related fluctuations 4, 5.

3. Monitor for ESRD Complications

Check the following regularly 1:

Electrolyte abnormalities:

• Serum potassium (risk of hyperkalemia, especially with RAS inhibitors)
• Serum bicarbonate (metabolic acidosis common)
• Calcium and phosphate

Anemia:

• Hemoglobin levels
• Iron studies if indicated

Metabolic bone disease:

• Serum calcium, phosphate, PTH
• Vitamin 25(OH)D levels

Volume status:

• Weight monitoring
• Signs of volume overload (edema, elevated BP)

4. Medication Safety Critical Points

Avoid or adjust these medications 6:

• NSAIDs: Absolutely avoid at eGFR <30 6
• Metformin: Avoid at eGFR <30 due to lactic acidosis risk 6
• Gadolinium contrast: Do not use at eGFR <15 unless no alternative exists 6
• Oral phosphate bowel preparations: Contraindicated 6

Dose adjustments needed:

• Beta-blockers: Reduce dose by 50% 6
• Digoxin: Adjust based on plasma levels 6
• Insulin: May need dose reduction (partly renally excreted) 6
• Most antibiotics require adjustment 6

5. Cardiovascular Risk Management

At age 34 with ESRD, she faces dramatically elevated cardiovascular mortality risk 7. Address:

• Anemia correction (improves cardiac outcomes)
• Lipid management (statins are safe; simvastatin 20mg shows no increased toxicity at low eGFR) 6
• Smoking cessation if applicable
• Dietary sodium restriction (crucial for volume control and BP management) 5, 8

6. Special Considerations for Young Women

Pregnancy counseling is essential. With ESRD:

• Pregnancy carries very high maternal and fetal risks
• ACE inhibitors/ARBs are teratogenic and must be stopped if pregnancy planned
• Contraception discussion is critical
• If she desires future pregnancy, kidney transplantation offers better outcomes than dialysis

7. Volume Management Strategy

Volume control is the cornerstone of hypertension management in ESRD 4, 5. Once dialysis begins:

• Ultrafiltration targets must be individualized
• Dietary sodium restriction (<2g/day) is critical
• Interdialytic weight gains should be minimized
• Antihypertensive medications are adjunctive to volume control

Common Pitfalls to Avoid

1. Don't discontinue RAS inhibitors solely based on low eGFR - they remain nephroprotective and cardioprotective even at eGFR <15 2

2. Don't panic over small creatinine rises (<30%) when starting/continuing RAS inhibitors - this is hemodynamic and acceptable 1, 2

3. Don't use combination ACE inhibitor + ARB - this increases adverse events without benefit 1, 2

4. Don't overlook residual kidney function - even small amounts of native kidney function improve outcomes and should be preserved

5. Don't delay dialysis access planning - arteriovenous fistula creation takes months to mature; plan ahead

What Happens Next

She will likely need dialysis initiation within weeks to months. The nephrology team will:

• Determine optimal dialysis modality based on her lifestyle, anatomy, and preferences
• Create vascular or peritoneal access
• Evaluate for kidney transplant candidacy (young age favors transplantation)
• Initiate dialysis when uremic symptoms develop or eGFR approaches 5-10 mL/min/1.73 m²

Her young age makes this particularly tragic but also means she's an excellent transplant candidate, which offers significantly better long-term outcomes than chronic dialysis.